Dollars for Docs logo

Dollars for Docs

Drug companies have long kept secret details of the payments they make to doctors and other health professionals for promoting their drugs. But 12 companies have begun publicizing the information, some because of legal settlements. ProPublica pulled their disclosures into a database so patients can search for their doctor. Accepting payments isn’t necessarily wrong, but it can raise ethical issues. Read more about the data »

Updated Sept. 7, 2011.

Has Your Health Professional Received Drug Company Money?

Search by name, by affiliated business or institution, or by city.

About this Database

$761.3 million

Our Stories

Pills-desat

Piercing the Veil, More Drug Companies Reveal Payments to Doctors

An update of ProPublica’s Dollars for Docs database includes more than $760 million in payments from 12 pharmaceutical companies to physicians and other health-care providers for consulting, speaking, research and expenses.

Also:

Payments in Your State

Click on a state name to see the disclosed payments made to healthcare practitioners there. Notes: Allergan is not included in the state or national totals because it reports payments in ranges. Also, Valeant did not report payments in the fourth quarter of 2010.

Name Total
Alabama $11,088,674
Alaska $263,333
Arizona $12,171,278
Arkansas $4,953,714
California $89,422,406
Colorado $13,383,820
Connecticut $10,835,250
Delaware $1,921,487
District of Columbia $3,619,223
Florida $56,001,451
Georgia $20,014,467
Hawaii $1,415,005
Idaho $2,555,576
Illinois $24,988,591
Indiana $13,878,303
Iowa $5,215,997
Kansas $9,223,710
Kentucky $10,909,633
Louisiana $8,502,889
Maine $1,244,415
Maryland $18,635,466
Massachusetts $22,135,703
Michigan $21,542,619
Minnesota $10,706,336
Mississippi $4,447,250
Missouri $18,902,337
Montana $692,983
Nebraska $5,059,794
Nevada $5,273,745
New Hampshire $2,742,608
New Jersey $21,773,190
New Mexico $2,166,325
New York $60,145,727
North Carolina $29,592,466
North Dakota $1,322,998
Ohio $33,819,224
Oklahoma $6,303,237
Oregon $5,937,530
Pennsylvania $40,064,872
Rhode Island $5,664,244
South Carolina $10,073,500
South Dakota $803,491
Tennessee $20,863,412
Texas $59,499,510
Utah $7,586,132
Vermont $768,856
Virginia $13,170,777
Washington $11,909,748
West Virginia $3,343,424
Wisconsin $9,229,426
Wyoming $319,996
Puerto Rico $4,789,479
[Unknown State] $389,294

Company Disclosures

The totals listed here range widely in scope and time period, and so aren't directly comparable. Some companies have added new data since we last downloaded their information.

Name Total
Allergan
Disclosure period: Q3 through Q4, 2010
n/a
AstraZeneca
Disclosure period: Q1, 2010 through Q1, 2011
$37.2 M
Cephalon
Disclosure period: Q1, 2009 through Q2, 2011
$49.3 M
EMD Serono
Disclosure period: Q1, 2011
$257 K
Eli Lilly
Disclosure period: Q1, 2009 through Q1, 2011
$206.1 M
GlaxoSmithKline
Disclosure period: Q2, 2009 through Q1, 2011
$147.2 M
Johnson & Johnson
Disclosure period: Q1 through Q4, 2010
$17.9 M
Merck
Disclosure period: Q3, 2009 through Q4, 2010
$29.8 M
Novartis
Disclosure period: Q4, 2010
$7.6 M
Pfizer
Disclosure period: Q3, 2009 through Q1, 2011
$259.6 M
Valeant
Disclosure period: Q1, 2010 through Q1, 2011
$477.2 K
ViiV
Disclosure period: Q1 through Q4, 2010
$4.3 M